drugset / Trial / NCT03136237
A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is an open-label, three part study to evaluate the effect of BCX7353 on drug transporters as well as the effect of an inhibitor of drug transport on BCX7353.
Timeline
- Start
- 2017-02-17
- Primary completion
- 2017-08-15
- Completion
- 2017-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 600 mg | Oral |
| Subject | Digoxin | Other / unclassified | 0.25 mg | Oral |
| Subject | Rosuvastatin | Small molecule | 10 mg | Oral |
| Subject | berotralstat | Small molecule | 350 mg | Oral |